SPOTLIGHT -
Spotlight: The Psychiatric Times Editorial Board at APA 2024
Our Editorial Board members are delivering expert perspectives on a wide variety of psychiatric issues and disorders.
Presenting Our May Theme: Mental Health Awareness
Write to us now to be part of our series focused on mental health awareness this month.
DEA Moves to Reclassify Marijuana as a Schedule III Drug
The proposed change acknowledges the medical applications of marijuana.
Psychiatry in the News: April 2024
Here are some updates from the world of psychiatry throughout the month of April.
From the Pages of Psychiatric Times: April 2024
The experts weighed in on a wide variety of psychiatric issues for the April issue of Psychiatric Times.
The Week in Review: April 22-26
Here are highlights from the week in Psychiatric Times.
PTSD Research Roundup: April 26, 2024
What is new in research on posttraumatic stress disorder?
The Week in Review: April 15-19
Opioid Use Disorder Research Roundup: April 19, 2024
What is new in research on opioid use disorder?
NeuroStar TMS and the Future of MDD Treatment for Adolescents
What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?
Tris Digital Health Forms, Will Focus on Digital Diagnostic Platform for ADHD
Tris Pharma has formed the organization along with a licensing agreement with Braingaze for development, distribution of the technology.
Publication of Phase 1 Results Announced for BPL-003
Study results suggest the potential for a scalable, single-dose treatment approach.
SUDs in Women and the Importance of Tailored Treatment Approaches
What are the most effective approaches to SUD treatment in this unique patient population?
Telehealth for the Treatment of OUD in Pregnant Patients
How can telehealth aid in the treatment of opioid use disorders in this patient population?
In Conversation With a Sigourney Award Winner: The Intersection Between Psychoanalytic Thought and Social Anthropology
Rosine Perelberg, PhD, discusses psychoanalytic thought, social anthropology, and the future of psychoanalysis.
The Week in Review: April 8-12
From a look at record-high suicide rates to subspecialty shortages in psychiatry, here are highlights from the week in Psychiatric Times.
Study Finds That Probiotics, Vitamin D May Enhance Cognitive Function in Schizophrenia
Researchers investigated the effects of this supplementation on cognitive function and disease severity in schizophrenia. Here’s what they found.
Schizophrenia Research Roundup: April 12, 2024
What is new in research on schizophrenia?
Addiction & Substance Use in Psychiatric Times
Take a look back at our recent coverage relating to our April content theme.
The Week in Review: April 1-5
From a groundbreaking FDA approval to the hidden toll of COVID-19, here are highlights from the week in Psychiatric Times.
Alcohol Use Disorder Research Roundup: April 5, 2024
What is new in research on alcohol use disorder?
National Alcohol Screening Day 2024
In honor of this year’s National Alcohol Screening Day, here’s a look back at some recent coverage in Psychiatric Times about the diagnosis, treatment, and management of alcohol misuse.
FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review
This alters the course of developer Eisai's regulatory submission plans for lecanemab in the treatment of early Alzheimer disease.
First Patient Dosed in Phase 2 Clinical Trial of NBI-1070770 for MDD
“The selectivity of NBI-1070770 for the NMDA NR2B receptor may benefit patients with moderate to severe depression.”
FDA Approves Fanapt for Mixed, Manic Episodes Associated With Bipolar I Disorder
The atypical antipsychotic was approved for the acute treatment of schizophrenia in 2009.
Presenting Our April Theme: Addiction and SUDs
Write to us now to be part of our series focused on addiction and substance use disorders this month.
From the Pages of Psychiatric Times: March 2024
The experts weighed in on a wide variety of psychiatric issues for the March 2024 issue of Psychiatric Times.
The Week in Review: March 25-29
From a promising new intervention for treatment-resistant depression to another look at the STAR*D controversy, here are highlights from the week in Psychiatric Times.
An Update on Bipolar I Disorder
Our Mood Disorders Section Editor discusses the disorder in honor of World Bipolar Day.
Psychiatry in the News: March 2024
Here are some updates from the world of psychiatry throughout the month of March.